Aurobindo Pharma Ltd (AUROPHARMA)

πŸ“Š End of Day Bhavcopy

Date: 2025-09-09

Price: 1048.20
% Change: 0.60% (Prev Close: 1041.90)

Volume: 10,36,358
% Change: 149.27% (Prev Volume: 4,15,761)

Delivery: 6,10,814
Delivery % : 58.94
% Change: 274.73% (Prev Delivery: 1,63,001)

Turnover: 10,809 Lacs
% Change: 149.15% (Prev Turnover: 4,338)

πŸ’Ή EOD Valuation

P/E Ratio: 18.11
P/B Ratio: 1.88
Market Cap: 61414 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: AUROPHARMA
Market Cap: 60229 Rs. Cr.
Face Value: 1.00 Rs.

52 Week High: 1592.55
52 Week Low: 994.35

All-Time High: 1592.55 Rs.
All-Time Low: 10.13 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-4.11% | -10.87% | -5.70% | -33.24% | 24.25%

πŸ‘₯ Shareholding Pattern

Promoter Holding

Promoter Holding: 51.81%

Change (3Y | 1Y): -0.02% | -0.01%

Pledged %: 17.08%

FII Holding

FII Holding: 14.38%

Change (3Y | 1Y): -6.33% | -0.95%

DII Holding

DII Holding: 26.93%

Change (3Y | 1Y): 9.63% | 0.70%

Public Holding: 6.88%

🏦 Financial Strength

Debt to Equity: 0.25
Debt: 8262.87 Rs. Cr.

Book Value: 557.28 Rs.
Current Ratio: 1.85
Interest Coverage: 12.15
Free Cash Flow: 1407.91 Rs. Cr.

πŸ“ˆ Growth & Sales

Sales Growth: 7.76%

Sales Growth Qtr (YOY | QoQ):
3.98% | -6.13%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
6.55% | 10.59% | 7.76%

πŸ’° Profit & Earnings

Profit Growth %

Profit Growth: -5.45%

Profit Growth Qtr (YOY | QoQ):
-10.28% | -8.71%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
3.87% | 7.90% | -5.45%

EPS Rs.

EPS (TTM): 57.88 Rs.

EPS Qtr (Last Year | Latest):
15.69 Rs. | 14.08 Rs.

EPS Annual (Last Annual | Annual March):
54.15 Rs. | 59.49 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
3.87% | 7.90%

Net Profit Rs. Cr.

Net Profit (TTM): 3389.55 Rs. Cr.

Net Profit (Annual - March): 3483.57 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
918.22| 902.83 | 824.20

EBITDA Rs. Cr.

EBITDA (Quarter): 1710.25 Rs. Cr.
EBITDA (Previous Yr Ql): 1839.11 Rs. Cr.

EBITDA (Annual - March): 7139.42 Rs. Cr.
EBITDA (Previous Annual): 6359.63 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
7.21% | 15.06%

πŸ“Š Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 20.32%

OPM Qtr (Previous | Current):
20.99% | 20.37%

OPM Annual (5 Yrs | Last Yr | March):
19.25% | 20.09% | 20.65%

Return on Equity %

ROE: 11.08%

ROE (5 Yrs | 3 Yrs | Last Yr):
11.59% | 10.15% | 11.55%

Return on Capital Employed %

ROCE: 14.18%

ROCE (5 Yrs | 3 Yrs | Last Yr):
13.79% | 12.49% | 14.10%

Return on Assets %

ROA (TTM): 7.35%

ROA (5 Yrs | 3 Yrs | Last Yr):
7.91% | 6.79% | 7.76%

PEG Ratio: 2.25
Dividend Yield: 0.44%

PE 3 Yrs: 20.29
PE 5 Yrs: 17.22

Dividend Yield: 0.44%

πŸ‘₯ Company

Aurobindo Pharma Ltd

AUROPHARMA

Promoter Holding: %